LTFS
ZVRA icon

Ladenburg Thalmann Financial Services’s Zevra Therapeutics ZVRA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Buy
572
+63
+12% +$500 ﹤0.01% 4989
2019
Q3 		$6K Hold
509
– – ﹤0.01% 4631
2019
Q2 		$14K Hold
509
– – ﹤0.01% 4279
2019
Q1 		$14K Sell
509
-13
-2% -$478 ﹤0.01% 4218
2018
Q4 		$15K Buy
+522
New +$21.1K ﹤0.01% 4049

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RFN
RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ZVRA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Zevra Therapeutics (ZVRA) stake by 12% in Q4 2019, buying an estimated $500 and bringing the position to 572 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4989.

Ladenburg Thalmann Financial Services first reported a position in ZVRA in Q4 2018 and has held it in 5 quarters since. The position peaked at $15K in Q4 2018. 27 funds tracked by Wall St. Rank hold ZVRA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 572 shares of Zevra Therapeutics worth $3K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 63 Zevra Therapeutics shares in Q4 2019, an estimated $500.
  • Zevra Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4989 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Zevra Therapeutics in Q4 2018 and has held it in 5 quarters since.
  • Ladenburg Thalmann Financial Services's Zevra Therapeutics position peaked at $15K in Q4 2018.
  • 27 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.